This week, the Apparently, the Medicines Health Products Regulatory Authority (MHRA) issued four emergency drugs recall notices in June 2007. Almost half of a batch of 70,000 fake drugs are still unaccounted for.
You won’t be surprised to learn that the fakes were parallel imports. A former industry investigator is quoted as saying: "All three medicines would have pretended to be medicines that were destined for other European markets..."
I often criticize parallel trade in the EU because it is (by definition) diversion, i.e., the sale of a drug outside of the distribution channels for which it was originally intended. Although many (most?) parallel trade products may be legit, it’s logical to me that any type of diversion will open up gateways for counterfeits.
So, "Where are the bodies?" That is, where is the unpleasant evidence that counterfeit drugs entered a supply chain?
As the BBC dryly notes in How fake drugs got into the NHS: "The fate of his potential British victims may never be known because no-one knows who took the drugs, and because of that, no-one knows whether anyone died as a result or what effect it has had on people’s treatment."
=======
Bye bye, Tom Daschle! Gosh, I was kinda looking forward to complaining about your support of drug importation, especially with a re-launch of the Friday the 13th franchise on the way.
Was he treated fairly for accepting money from the industry that he would be regulating? As one average American opined: "It's still not as bad as the $400,000 that Interior Secretary Ken Salazar has received from the geyser and
=======
Check out the all-new Health Wonk Review for the best in health care blogging from around the web.
